EU Ministers Press Commission On Delayed REACH Revision Amid Industry And Environmental Demands

Dr Steven Brennan
Dr Steven Brennan
3 min readAI-drafted, expert reviewed
Papers on a desk

Key takeaway

What This Development Means

EU Member States are urging swift action on the long-delayed REACH revision to address outdated procedures and bolster both health protections and industrial resilience. The Commission has pledged reform, but with no timeline in sight, political pressure is mounting.

What is the REACH Regulation and why is it being revised?

REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) is the EU's flagship chemical regulation. The revision aims to modernise the framework to improve health and environmental safety while reducing regulatory complexity for industry.

How will the REACH revision impact manufacturers and importers?

The proposed shift from individual authorisations to broader restrictions could simplify compliance, speed up decisions, and enhance regulatory predictability, particularly benefiting SMEs and import-dependent sectors. However, exact impacts will depend on the final legislative design.

Source basis: https://video.consilium.europa.eu/event/en/28167

On 21 October 2025, Sweden, backed by a coalition of Member States, raised the alarm over the stalled revision of the REACH Regulation during the Environment Council’s public session in Luxembourg. The move, under the "Any Other Business" agenda item, reignited political pressure on the European Commission to advance long-promised updates to the EU’s core chemicals legislation, Regulation (EC) No 1907/2006.

The primary keyword in focus, REACH revision, holds significant implications for professionals across the chemicals value chain. Sweden underscored the need for a comprehensive modernisation of the regulation to better safeguard human health and the environment, while enhancing legal clarity and global competitiveness for the EU’s industrial base.

Lithuania, the Netherlands, Czechia, Hungary, and Slovakia echoed these concerns, collectively demanding transparency on the status and timeline of the proposal. Hungary explicitly requested a detailed explanation of internal obstacles delaying progress. France and Luxembourg lent cautious support but warned that simplification efforts must not dilute environmental and safety ambitions.

Widespread Support Highlights REACH Reform’s Strategic Importance

The widespread support highlights REACH's evolving role in addressing today’s environmental and industrial realities. Since its adoption in 2006, REACH has established a global benchmark for chemical safety. However, Member States now warn that the system has grown administratively burdensome and outdated, hindering effective regulation and innovation.

According to the Commission, the revised REACH framework remains a central element of the EU’s Chemicals Strategy for Sustainability, part of the European Green Deal. A key aim of the revision is to shift from case-by-case authorisations toward faster, broader restrictions on hazardous substances. This would accelerate decision-making and reduce bureaucracy.

Key Objectives: Digitalisation, Enforcement, And Risk Reduction

Beyond authorisation streamlining, the Commission’s update will target:

  • Improved supply chain communication through digitalisation
  • Reduction in animal testing by promoting alternative methods
  • Strengthened border enforcement to block non-compliant imports, especially via e-commerce
  • A more robust evidence base for regulatory decision-making

While no definitive timeline was confirmed, the Commission reaffirmed its commitment to delivering a “proportionate and effective” revision aligned with the goals of the Chemicals Strategy and the broader European Green Deal.

Get weekly regulatory updates:

Related Articles

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX